S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

MURA Mural Oncology PLC

3.73

0.38 (11.34%)

Pre Market

Last Updated: 07:19:25

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Mural Oncology (NASDAQ:MURA)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Mural Oncology Charts.

Mural Oncology (NASDAQ:MURA)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Mural Oncology Charts.

Mural Oncology PLC News

Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
Wednesday 20 November 2024 (5 days ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Tuesday 19 November 2024 (5 days ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress
Wednesday 13 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Mural Oncology to Participate in Two Upcoming Investor Conferences
Monday 11 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Thursday 7 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Monday 4 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Monday 7 October 2024 (2 months ago) • GlobeNewswire Inc.

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 2 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 26 September 2024 (2 months ago) • Edgar (US Regulatory)

More Mural Oncology PLC News Articles

INTESA SANPAOLO

SG Issuer Societe Generale

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions